JPMorgan Chase & Co’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-101,118
Closed -$203K 4918
2018
Q1
$203K Buy
101,118
+99,018
+4,715% +$199K ﹤0.01% 3717
2017
Q4
$3K Sell
2,100
-18,760
-90% -$26.8K ﹤0.01% 4593
2017
Q3
$26K Buy
20,860
+4,200
+25% +$5.24K ﹤0.01% 3938
2017
Q2
$22K Buy
16,660
+510
+3% +$673 ﹤0.01% 3914
2017
Q1
$30K Sell
16,150
-8,713
-35% -$16.2K ﹤0.01% 4040
2016
Q4
$129K Buy
+24,863
New +$129K ﹤0.01% 3809